glp-1 agonists long term side effects The expanding role of receptor agonists: a narrative review of current evidence and future directions Mapping the effectiveness and risks
Description
Market leader Lilly is developing its own amylin analogue called eloralintide that's already in Phase 3 trials
Obes Rev, 2025
Afr Health Sci
Reactions were incubated for 30 min at room temperature in white, clear-bottom microtiter plates, and per cent of the maximal response was calculated using control wells as a reference
